CRDF
Cardiff Oncology·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CRDF fundamentals
Cardiff Oncology (CRDF) released its earnings on Nov 6, 2025: revenue was 120.00K (YoY -27.27%), missed estimates; EPS was -0.17 (YoY +32.00%), beat estimates.
Revenue / YoY
120.00K
-27.27%
EPS / YoY
-0.17
+32.00%
Report date
Nov 6, 2025
EPS
Revenue
Revenue & Expenses
CRDF has released its 2025 Q3 earnings report, with revenue of 120.00K, reflecting a YoY change of -27.27%, and net profit of -11.26M, showing a YoY change of 5.04%. The Sankey diagram below clearly presents CRDF's revenue sources and cost distribution.
Key Indicators
Cardiff Oncology (CRDF) key financial stats and ratios, covering profitability, financial health, and leverage.
Cardiff Oncology (CRDF)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Cardiff Oncology (CRDF)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cardiff Oncology (CRDF)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Cardiff Oncology (CRDF) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Cardiff Oncology (CRDF) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Cardiff Oncology year over year?What is Cardiff Oncology's gross profit margin?What factors drove the changes in Cardiff Oncology's revenue and profit?What guidance did Cardiff Oncology's management provide for the next earnings period?What were the key takeaways from Cardiff Oncology’s earnings call?What is Cardiff Oncology's latest dividend and current dividend yield?What were the key takeaways from Cardiff Oncology's earnings call?Did Cardiff Oncology beat or miss consensus estimates last quarter?
